moderate statin dose
PreclinicalSmall molecule
moderate statin dose is one of 10 small molecule programs targeting Statin. It is currently in Preclinical.
1
Indications
1
Total Trials
0
Active Trials
9
Competitors
Pipeline
Status by Indication[3][1]
Competition
Competitive Landscape
10 competitors in Statin
#DrugCompanyPhaseTrials
1Crestor
AstraZenecaApproved
Lipitor
PPfizer's Upjohn has merged with Mylan to form Viatris Inc.
Approved
Somatostatin Analog
UUniversity of Aarhus
Phase 3
Intensive Statin Treatment
UUnion Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase 3
Octreotide
Johnson & JohnsonPreclinical
VNZ/TEZ/D-IVA
Vertex PharmaceuticalsPhase 1
Bryostatin 1
NNational Cancer Institute (NCI)
Phase 1
Test Drug
Chong Kun Dang PharmaceuticalPreclinical
Reference Drug
Chong Kun Dang PharmaceuticalPreclinical
moderate statin dose
SShiraz University of Medical Sciences
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for moderate statin dose. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details